Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Chugai Pharmaceutical Co Ltd    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO LTD (4519)
My previous session
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Financials (JPY)
Sales 2018 558 B
EBIT 2018 112 B
Net income 2018 85 807 M
Finance 2018 216 B
Yield 2018 0,98%
Sales 2019 613 B
EBIT 2019 142 B
Net income 2019 105 B
Finance 2019 235 B
Yield 2019 1,19%
P/E ratio 2018 44,39
P/E ratio 2019 35,76
EV / Sales2018 6,66x
EV / Sales2019 6,02x
Capitalization 3 929 B
More Financials
Company
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals.Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety.The... 
Sector
Pharmaceuticals
Calendar
10/26Earnings Release
More about the company
Surperformance© ratings of Chugai Pharmaceutical Co L
Trading Rating : Investor Rating :
More Ratings
Latest news on CHUGAI PHARMACEUTICAL CO L
09/21CHUGAI PHARMACEUTICAL : Announcement Regarding the Order to Dismiss in a Lawsuit..
AQ
09/21CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Service..
PU
09/18CHUGAI PHARMACEUTICAL : Organizational and Personnel Changes
AQ
09/18CHUGAI PHARMACEUTICAL : Selected for the Fourth Time for Dow Jones Sustainabilit..
AQ
09/06CHUGAI PHARMACEUTICAL : New Antineoplastics Study Findings Have Been Reported by..
AQ
09/06CHUGAI PHARMACEUTICAL : Results of Global Phase III Study with Chugai's HEMLIBRA..
AQ
08/31CHUGAI PHARMACEUTICAL : Results of Global Phase III Study with Chugai's HEMLIBRA..
AQ
08/31CHUGAI PHARMACEUTICAL : Results of Global Phase III Study with Chugai`s HEMLIBRA..
AQ
08/30Chugai Pharmaceutical Co., Ltd. - Launch of the Anti-Cancer Agent a Humanized..
AQ
08/30CHUGAI PHARMACEUTICAL : Obtains 'Platinum Kurumin' Certification from the Minist..
AQ
More news
Sector news : Pharmaceuticals - NEC
08:30aASTRAZENECA : Mixed Results from Farxiga Trial
DJ
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
03:05aAs China builds biotech sector, cash floods U.S. startups
RE
09/23ASTRAZENECA CEO WARNS OF MEDICINE SH : Sunday Times
RE
09/22J&J UNIT : Esketamine Study Didn't Show Statistical Significance for Primary End..
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
09/21Chugai Pharmaceutical : Contribution of Para-transit Vehicles to Welfare Serv.. 
09/03$4519 Pharmaceutical Co. Ltd. Were Slightly Increasing Our Chugai FVE Follow.. 
08/29$Tokyo Stock Exchange Pharmaceutical Co Ltd Sumitomo Dainippon Pharma Co Ltd.. 
08/29Chugai Pharmaceutical : Launch of the Anti-Cancer Agent / a Humanized Anti-CD.. 
07/26It's earningspalooza today in healthcare! $RHHBY, $AZN, $BMY, $BAX, $MCK, $AG.. 
More tweets
Qtime:35
News from SeekingAlpha
07/27Chugai Pharmaceutical Co., Ltd. ADR 2018 Q2 - Results - Earnings Call Slides 
05/31ALEXION PHARMACEUTICALS : Clinical Progress, Acquisitions And The Competition (P.. 
04/27Chugai Pharmaceutical's (CHGCF) Management on Q1 2018 Results - Earnings Call.. 
04/25Chugai Pharmaceutical Co., Ltd. ADR 2018 Q1 - Results - Earnings Call Slides 
04/24Chugai Pharmaceutical reports Q1 results 
Chart CHUGAI PHARMACEUTICAL CO LTD
Duration : Period :
Chugai Pharmaceutical Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO L
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 5 927  JPY
Spread / Average Target -16%
EPS Revisions
Managers
NameTitle
Tatsuro Kosaka President, CEO & Representative Director
Osamu Nagayama Chairman
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Hisanori Takanashi Manager-R&D Portfolio Management Department
Sector and Competitors
1st jan.Capitalization (M$)
CHUGAI PHARMACEUTICAL CO LTD21.66%34 889
JOHNSON & JOHNSON2.26%383 312
PFIZER21.65%258 285
NOVARTIS-0.63%216 108
ROCHE HOLDING LTD.-4.60%211 501
MERCK AND COMPANY26.36%189 092